Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Skin aging reflects overall body aging and can indicate internal health conditions.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Minoxidil, when applied to the scalp, can stimulate hair growth but effects vary, stop if treatment ends, and it may cause side effects like fluid retention.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

The treatment promotes hair growth, improves hair density, and reduces skin irritation.

Ingesting minoxidil can cause serious heart problems and requires urgent medical treatment.

RF-based therapies might help treat hair loss.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Certain metabolites can either protect against or increase the risk of hair loss.

Minoxidil patches and cold plasma may help treat hair loss.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

A 3-year-old with vitamin D-resistant rickets and severe hair loss died despite treatment, highlighting the need for improved management of the condition.

Lipids from Schizochytrium sp. help prevent hair loss by protecting hair cells from damage and promoting hair growth.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Cellcurex™ treatment increased hair growth and thickness but caused pain and bleeding.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

The document is a detailed medical reference on skin and genetic disorders.